In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
about
Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsExpanding the clinical indications for α(1)-antitrypsin therapyProteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging.Common coding variant in SERPINA1 increases the risk for large artery stroke.Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosisThe association between adiponectin, HDL-cholesterol and α1-antitrypsin-LDL in female subjects without metabolic syndromeScavenger receptor class B, type I-mediated uptake of A1AT by pulmonary endothelial cellsThe effects of weight gain after smoking cessation on atherogenic α1-antitrypsin-low-density lipoprotein.Rosuvastatin Alters the Proteome of High Density Lipoproteins: Generation of alpha-1-antitrypsin Enriched Particles with Anti-inflammatory PropertiesThe effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid markerHighly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPDTime-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophilsHighly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.High levels of iron status and oxidative stress in patients with metabolic syndrome.Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.
P2860
Q26858837-4E7067B0-27A0-4F97-9CD6-C667C629ED12Q27000764-ED0B67DA-5A12-461C-BEC8-8A0F1A1528D4Q33239791-CF3BD2A2-2FFC-435D-A870-6C991ACCCC57Q33556760-0107FAE6-CB87-4DDF-89A5-816FE7934CBEQ34390616-FBE97096-03F8-461F-BDBF-9C01877B2ED5Q34478204-108BCD0D-28DE-4DEE-A6CE-153012B853DAQ35959814-47931A75-B72D-439A-AC73-34B8EB5CBCAFQ36289898-DA99D0B8-7549-438B-8803-6031C75EEE00Q36604395-CA609CEF-C655-46A1-8B45-693C2F563029Q36935026-D189809B-101D-41C0-88E4-22A9EF412BAEQ37225778-681F439C-84A5-47A5-B3F7-832429BFAB18Q37420498-C1D023A0-174F-4CE5-8629-DC0391986C1DQ39565971-57528D72-04E2-4612-BAA5-6A73431C8213Q43274967-44918696-F18C-4154-9892-F54677698CA1Q51350120-89E78077-1A66-403B-94B7-1976AD43133DQ51465416-68C43EA4-63CE-4BEB-9343-B36F2CA5CB40Q55438350-879B773C-CB53-4306-8965-7DC299445441
P2860
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
In vivo complex formation of oxidized alpha
@nl
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@ast
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@en
type
label
In vivo complex formation of oxidized alpha
@nl
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@ast
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@en
prefLabel
In vivo complex formation of oxidized alpha
@nl
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@ast
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@en
P2093
P356
P1476
In vivo complex formation of oxidized alpha(1)-antitrypsin and LDL.
@en
P2093
Hamakubo T
Kobayashi M
Nakamura A
Sugiyama A
P304
P356
10.1161/HQ1101.098232
P407
P577
2001-11-01T00:00:00Z